ImmunoMet Therapeutics today announced the appointment of Benjamin R. Cowen, PhD, MBA, as Chief Executive Officer, effective November 1, 2017. Dr. Cowen previously held the position of Chief Operating Officer.
ImmunoMet Therapeutics today announced the appointment of Benjamin R. Cowen, PhD, MBA, as Chief Executive Officer, effective November 1, 2017. Dr. Cowen previously held the position of Chief Operating Officer.